JENA HAMM: Open Payments
NPI 1073866489 · RUSSELLVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 18 payments from 11 companies in 2025. Trend: 2023 $473 · 2024 $721 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 1 | $127 |
| Novo Nordisk Inc | 1 | $120 |
| Axsome Therapeutics, Inc. | 1 | $113 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 1 | $35 |
| Lilly USA, LLC | 2 | $33 |
| Exact Sciences Corporation | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: VOQUEZNA, Ozempic, Auvelity, Kerendia, BREZTRI, REXULTI, ZORYVE, MOUNJARO.
Industry payments across AL — which companies pay providers there.
